[1]李碧军),郭瑞霞),王春芳),等.p16/Ki67双染、HPV E6/E7 mRNA检测对于TCT检查为低级别鳞状上皮内病变及以下且HPV检测为阴性或其他高危型HPV阳性患者的分流作用[J].郑州大学学报(医学版),2021,(01):11-15.
　LI Bijun),GUO Ruixia),WANG Chunfang),et al.Role of p16/Ki67 dual staining and HPV E6/E7 mRNA detection for triage in patients with LSIL or lower lesions diagnosed by TCT and HPV negative or other high-risk HPV positive[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2021,(01):11-15.
点击复制

p16/Ki67双染、HPV E6/E7 mRNA检测对于TCT检查为低级别鳞状上皮内病变及以下且HPV检测为阴性或其他高危型HPV阳性患者的分流作用()
分享到：

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2021年01期
页码:
11-15
栏目:
论著
出版日期:
2021-01-20

文章信息/Info

Title:
Role of p16/Ki67 dual staining and HPV E6/E7 mRNA detection for triage in patients with LSIL or lower lesions diagnosed by TCT and HPV negative or other high-risk HPV positive
作者:
李碧军1); 郭瑞霞1); 王春芳1); 陈 曦1); 褚丹霞1); 王凯丽2); 杜建敏1); 白 晶1)
1)郑州大学第一附属医院妇科 郑州 450052 2)郑州大学第三附属医院妇科 郑州 450052
Author(s):
LI Bijun1);  GUO Ruixia1);  WANG Chunfang1);  CHEN Xi1); CHU Danxia1);  WANG Kaili2);  DU Jianmin1);  BAI Jing1)
1)Department of Gynecology,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052 2)Department of Gynecology,the Third Affiliated Hospital,Zhengzhou University,Zhengzhou 450052
关键词:
TCT;  p16/Ki67双染色法;  高危HPV E6/E7 mRNA;  宫颈癌;  联合检测
Keywords:
TCT;  p16/Ki67 dual staining;  high-risk HPV E6/E7 mRNA;  cervical cancer;  combined detection
分类号:
R737.33
摘要:
目的:探索p16/Ki67双染色法(简称双染)、HPV E6/E7 mRNA(简称E6/E7)检测对于宫颈细胞学检查(TCT)为低级别鳞状上皮内病变(LSIL)及以下且HPV检测为阴性或其他高危型HPV阳性患者的分流作用。方法:收集郑州大学第一附属医院妇科门诊就诊的TCT检查为LSIL及以下且HPV检测为阴性或其他高危型HPV阳性(不包括HPV16、18阳性)的414例患者的宫颈脱落细胞,分别进行双染检测、HPV E6/E7 mRNA检测,并行阴道镜下活检,以组织病理学诊断为“金标准”,采用灵敏度、特异度比较TCT+HPV+双染、TCT+HPV+E6/E7和TCT+HPV检测用于筛查高级别鳞状上皮内病变及以上(HSIL+)患者的效能。结果:根据病理结果,414例中150例为HSIL+。TCT+HPV+双染检出宫颈HSIL+病变的灵敏度、特异度分别为78.7%、50.4%,TCT+HPV+E6/E7分别为74.0%、26.1%,而TCT+HPV为90.0%、8.0%。TCT+HPV+双染和TCT+HPV+E6/E7检出HSIL+病变的灵敏度相近,均略低于TCT+HPV(P<0.05),而TCT+HPV+双染的特异度远高于其他2种方法(P<0.05)。结论:对于TCT检查为LSIL及以下且HPV阴性或其他高危型HPV阳性患者,采用p16/Ki67双染联合检测具有较高的灵敏度,且能显著提高特异度,其筛查效能优于TCT和HPV联合筛查。
Abstract:
Aim:To investigate the application value of p16/Ki67 dual staining(dual staining)and HPV E6/E7 mRNA(E6/E7)detection for triage in patients with LSIL or lower lesions diagnosed by TCT and HPV negative or other high-risk HPV positive.Methods:A total of 414 patients with LSIL or lower lesions diagnosed by TCT and HPV negative or other high-risk HPV positive admitted by the First Affiliated Hospital of Zhengzhou University were collected. Cervical exfoliated cells were detected by dual staining and E6/E7 detection, and colposcopy biopsy was also performed. Taking histopathology as the gold standard,the sensitivity and specificity of TCT+HPV+dual staining,TCT+HPV+E6/E7,and TCT+HPV for diagnosing HSIL or higher lesion(HSIL+)were compared.Results:According to the results of biopsy, there were 150 cases of HSIL+ among 414 cases.The sensitivity and specificity of TCT+HPV+dual staining for detecting HSIL+ were 78.7% and 50.4%, those for TCT+HPV+E6/E7 were 74.0% and 26.1%,and those for TCT+HPV were 90.0% and 8.0%.The sensitivity of TCT+HPV+dual staining and TCT+HPV+E6/E7 were similar,lower than that of TCT+HPV(P<0.05), while the specificity of TCT+HPV+dual staining was higher than those of TCT+HPV+E6/E7 and TCT+HPV(P<0.05).Conclusion:When the screening results of cervical cancer are LSIL or lower lesions diagnosed by TCT and HPV negative or other high-risk HPV positive, p16/Ki67 dual staining combined detection can maintain high sensitivity and improve the specificity; its screening efficiency is better than TCT+HPV combined screening.

参考文献/References:

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394
[2] 赵宇倩,戴毅,党乐, 等.适合中国人群的宫颈癌筛查技术和效果评价的真实世界研究[J].中华肿瘤杂志,2018,40(10):764
ZHAO YQ,DAI Y,DANG L,et al.Real world research on cervical cancer screening program and effect evaluation for Chinese population[J].Chinese Journal of Oncology,2018,40(10):764
[3] CHEN W, ZHANG X, MOLIJN A, et al.Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18[J].Cancer Causes Control,2009,20(9):1705
[4] 李玉霞,宋晓婕,陈莉, 等.宫颈癌筛查中高危型HPV及液基细胞学联合应用的临床价值[J].中国妇幼保健,2015,30(3):479
[5] 李霞,黄文倩,陈婷婷, 等.2018美国预防服务工作组《宫颈癌筛查》指南解读[J].中国实用妇科与产科杂志,2019,35(4):435
[6] 吴忧,赵健,胡君, 等.免疫细胞化学p16/Ki-67双染色法检测对于细胞学诊断为ASCUS、LSIL和ASC-H患者分流的意义[J].中华妇产科杂志,2017,52(11):734
WU Y, ZHAO J, HU J,et al.Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H[J].Chinese Journal of Obstetrics and Gynecology,2017,52(11):734
[7] 李晓林,袁文娟,陈龙, 等.高危型HPV E6/E7 mRNA检测在宫颈机会性筛查中应用价值研究[J].中华肿瘤防治杂志,2017,24(4):217
LI XL,YUAN WJ,CHEN L,et al.Application hrHPV E6/E7 mRNA to study epidemiologic characteristics of the cervical opportunistic screening population[J].Chinese Journal of Cancer Prevention and Treatment,2017,24(4):217
[8] TSENG CW, WONG JB.Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement[J].JAMA,2018,320(7):674
[9] WRIGHT TC JR, MASSAD LS, DUNTON CJ, et al.2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests[J].Am J Obstet Gynecol,2007,197(4):346
[10]WRIGHT TC JR, STOLER MH, SHARMA A, et al.Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results[J].Am J Clin Pathol,2011,136(4):578
[11]SARI ASLANI F, SAFAEI A, POURJABALI M, et al.Evaluation of Ki67, p16 and CK17 markers in differentiating cervical intraepithelial neoplasia and benign lesions[J].Iran J Med Sci,2013,38(1):15
[12]SINGH M, MOCKLER D, AKALIN A, et al.Immunocytochemical colocalization of P16(INK4a)and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma[J].Cancer Cytopathol,2012,120(1):26
[13]REUSCHENBACH M, SEIZ M, VON KNEBEL DOEBERITZ C, et al.Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells[J].Int J Cancer, 2012,130(2):388
[14]李雨聪,雷海科,易琳, 等.p16/Ki-67双染在宫颈癌及癌前病变初筛中的应用价值研究[J].实用妇产科杂志,2017,33(10):760
LI YC,LEI HK,YI L,et al.Evaluation of p16/Ki-67 dual staining for cervical cancer and precancerous screening[J].Journal of Practical Obstetrics and Gynecology,2017,33(10):760
[15]BERGERON C, IKENBERG H, SIDERI M, et al.Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results[J].Cancer Cytopathol,2015,123(6):373
[16]ATKINS K.p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: p16/Ki-67 in cervical Papanicolaou tests[J].Cancer Cytopathol,2011,119(3):145
[17]KISSER A, ZECHMEISTER-KOSS I.A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology[J].BJOG,2015,122(1):64
[18]金蓉蓉,马红伟,陈天羽, 等.p16/Ki-67双染检测在意义不明的不典型鳞状细胞分流诊断中的应用[J].中华病理学杂志,2017,46(7):481
JIN RR,MA HW,CHEN TY,et al.Application of p16/Ki-67 immunocytochemistry in triage of patients with atypical squamous cells of undetermined significance[J].Chinese Journal of Pathology,2017,46(7):481
[19]于静,朱慧庭,赵晶晶, 等.p16INK4a/Ki-67双免疫细胞化学染色对宫颈细胞学不能明确意义的不典型鳞状细胞和低级别鳞状上皮内瘤变患者的分流作用[J].中华病理学杂志,2017,46(5):323
YU J,ZHU HT,ZHAO JJ,et al.Sorting role of p16INK4a/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases[J].Chinese Journal of Pathology, 2017,46(5):323
[20]WRIGHT TC JR, BEHRENS CM, RANGER-MOORE J, et al.Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial[J].Gynecol Oncol,2017,144(1):51
[21]DEPUYDT CE, BENOY IH, BEERT JF, et al.Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening[J].J Clin Microbiol,2012,50(12):4073

备注/Memo

备注/Memo:
【基金项目】国家自然科学基金面上项目(31670844); 中原千人计划-中原名医项目(ZYQR201810107); 河南省科技创新杰出人才项目(2018JR0004); 河南省医学科技攻关计划项目(省部共建)(SBGJ2018005)
【作者简介】郭瑞霞,通信作者,女,1972年3月生,博士,教授,研究方向:妇科肿瘤,E-mail: grxcdxzzu@163.com
更新日期/Last Update: 2021-02-15